申请人:Alnylam Pharmaceuticals Inc.
公开号:EP2239328A2
公开(公告)日:2010-10-13
This invention relates to methods and compositions for treating neurological disease, and more particularly to methods of delivering iRNA agents to neural cells for the treatment of neurological diseases.
本发明涉及治疗神经系统疾病的方法和组合物,尤其涉及向神经细胞递送 iRNA 制剂以治疗神经系统疾病的方法。